Carlos Nueno Sells 2,389 Shares of Teladoc Health, Inc. (NYSE:TDOC) Stock

Teladoc Health, Inc. (NYSE:TDOCGet Free Report) insider Carlos Nueno sold 2,389 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the sale, the insider now directly owns 2,890 shares in the company, valued at $34,477.70. This trade represents a 45.25 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Teladoc Health Stock Down 4.9 %

Shares of NYSE:TDOC opened at $10.94 on Wednesday. Teladoc Health, Inc. has a 12-month low of $6.76 and a 12-month high of $22.54. The stock’s 50-day moving average price is $9.44 and its two-hundred day moving average price is $9.22. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The firm has a market cap of $1.88 billion, a price-to-earnings ratio of -1.90 and a beta of 0.97.

Teladoc Health (NYSE:TDOCGet Free Report) last released its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.51 million for the quarter, compared to analysts’ expectations of $630.50 million. On average, research analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the company. JPMorgan Chase & Co. decreased their target price on Teladoc Health from $16.00 to $9.00 and set a “neutral” rating on the stock in a research report on Monday, August 26th. Evercore ISI boosted their price objective on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Cantor Fitzgerald restated an “overweight” rating and set a $10.00 target price on shares of Teladoc Health in a report on Tuesday, August 20th. Jefferies Financial Group lifted their target price on shares of Teladoc Health from $8.00 to $10.00 and gave the stock a “hold” rating in a research report on Tuesday, September 17th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Fourteen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, Teladoc Health currently has an average rating of “Hold” and an average target price of $12.08.

Read Our Latest Stock Analysis on Teladoc Health

Institutional Trading of Teladoc Health

Several institutional investors have recently made changes to their positions in TDOC. Connor Clark & Lunn Investment Management Ltd. increased its position in Teladoc Health by 15.5% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider’s stock worth $15,617,000 after purchasing an additional 228,004 shares in the last quarter. Clearline Capital LP grew its stake in Teladoc Health by 395.6% during the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock worth $42,682,000 after buying an additional 3,483,665 shares during the period. The Manufacturers Life Insurance Company increased its position in shares of Teladoc Health by 195.3% in the second quarter. The Manufacturers Life Insurance Company now owns 95,307 shares of the health services provider’s stock worth $932,000 after acquiring an additional 63,028 shares in the last quarter. Jennison Associates LLC purchased a new position in shares of Teladoc Health in the 3rd quarter valued at $1,544,000. Finally, Massachusetts Financial Services Co. MA raised its stake in shares of Teladoc Health by 477.1% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 370,093 shares of the health services provider’s stock valued at $3,397,000 after acquiring an additional 305,961 shares during the period. 76.82% of the stock is owned by hedge funds and other institutional investors.

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Further Reading

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.